93
/
2
Min Read
Precision oncology startup 4baseCare has raised INR 90 crore (USD 9.8 million) in the first close of its Series B funding round, co-led by investors Ashish Kacholia and Lashit Sanghvi, with participation from existing backer Yali Capital.
The round marks the startup’s first fundraising activity in nearly two years. In 2024, 4baseCare had raised USD 6 million in a Series A round led by Yali Capital, with participation from Infosys.
The round marks the startup’s first fundraising activity in nearly two years. In 2024, 4baseCare had raised USD 6 million in a Series A round led by Yali Capital, with participation from Infosys.
The expansion is aimed at increasing access to precision oncology services in regions where advanced genomic testing remains limited. The company said it plans to work closely with hospitals to integrate genomics-led diagnostics within routine clinical settings.
Alongside geographic expansion, 4baseCare plans to accelerate the development and deployment of its AI-driven clinical decision support tools. These include OncoTwin Insights, a platform designed to help oncologists interpret real-world clinico-genomic and outcomes-linked datasets to inform treatment decisions. The OncoTwin platform was recently selected for the MSK iHub program of Memorial Sloan Kettering Cancer Center, New York.
The expansion is aimed at increasing access to precision oncology services in regions where advanced genomic testing remains limited. The company said it plans to work closely with hospitals to integrate genomics-led diagnostics within routine clinical settings.
Investor interest in oncology-focused startups has increased in recent years. In 2025, several India-based cancer care companies reported funding activity. Everhope Oncology raised USD 10 million in seed funding, while MOC Cancer Care & Research Centre secured USD 18 million led by Elevation Capital. Startups such as ErlySign, OnCare, and OneCell Diagnostics have also attracted capital.
This article was originally
published by the 
